anonymous
Guest
anonymous
Guest
So it's announced in the British financial press that JNJ is going to make an offer for SN.L....and no one even comments on it. I find that fascinating.
Happened with Biomet too. People have become immune to the nonsenseBecause no one believes it will happen. This is a cyclical process with SNN where they throw out a potential buyer, it drives up the stock price for a few days, everyone in London makes a few more bucks in their portfolio and after a few weeks it turns out to be nothing. It happened with Stryker a couple of years ago. Makes the company seem relevant to the rest of the world when we all know it isn't.
JNJ has a lot of money stranded off shore. Can't bring this money directly to US without big tax bill. Therefore JNJ will most likely be buying a non-USA based company. Last go round (2011) JNJ bought Synthes. S&N is just one of many possible acquisitions this time - but definitely on the short list of potential targets.
please let this happen and replace everyone from healthpoint
Health point runs the show here at smith. They took control and things have taken off. Just the facts
Our wound care division has never been in worse condition. Your doing great.
Health point runs the show here at smith. They took control and things have taken off. Just the facts
please let this happen and replace everyone from healthpoint
Be very careful what you wish for. Ask the Synthes or DePuy people how much they liked being acquired by JnJ. If you think what you have now is dysfunctional, you aint seen nothing yet.
We know how the synthes merger went/still going on. Just need the stock price up a little right now. Easiest way is rumors of a buyout.